Combat Stress: Formation Mechanisms and Targets of Directed Pharmacological Effects

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The article is based on the materials of the report at the scientific session of the Department of Physiological Sciences of the Russian Academy of Sciences, dedicated to the physiology and pharmacology of extreme conditions. Taking into account the results of scientific research and the experience of organizing and providing medical care in modern armed conflicts, the targets and directions of pharmacological action to correct the functional state of the body are determined. Modern methods for maintaining the combat readiness of military personnel and the effectiveness of operator activities to create functional reserves of response to emerging vital threats are presented. The possibilities of combining drugs, the interaction of which provides the ability to reduce the doses of psychoactive components, increase safety and adherence to their use, are traced. The expediency of maintaining eubiosis and correcting disorders of the body's microbiota, which is involved in the formation of stress-mediated reactions, is indicated.

全文:

受限制的访问

作者简介

S. Chepur

State Scientific-Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation

编辑信件的主要联系方式.
Email: gniiivm_2@mil.ru
俄罗斯联邦, St. Petersburg

参考

  1. Evdokimov V.I., Rybnikov V.Yu., Shamrey V.K. [Combat stress: scientometric analysis of domestic publications (2005–2017)]. St. Petersburg: Politekhnika-print, 2018. 170 p.
  2. Ushakov I.B., Bubeev Yu.A. [Stress of deathful conditions as a special kind of stress] // Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2011. № 4. P. 5.
  3. Shamrey V.K., Lytkin V.M., Barazenko K.V., Zun S.A. [PTSD development and dynamics] // Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations. 2023. № 1. P. 68.
  4. Ryadinskaya E.N. [Features of the psychological states of a person residing in the area of armed conflict, in the context of the transformation of life strategies in the post-conflict period] // Psychology and Law. 2016. V. 6. № 4. P. 196.
  5. Ноge C.W. Interventions for war-related posttraumatic stress disorder: Meeting veterans where they are // JAMA. 2011. V. 306. № 5. P. 549.
  6. Pogodina T.G., Troshin V.D. [Dynamics of neuro-psychic disorders in war veterans] // Bull. Ivanovo Med. Acad. 2009. V. 14. № 1. P. 26.
  7. [Research Testing Center (Medical and Biological Defense) of the Federal State Institution “State Research Testing Institute of Military Medicine of the Ministry of Defense of the Russian Federation”]. On the 40th anniversary of its foundation / Ed. Ivanchenko A.V. St. Petersburg: RTC (MBD) SRTI MM DoD, 2009. 265 p.
  8. Chepur S.V., Fateev I.V., Shustov E.B. et al. [Loxidan: psychostimulant of new generation] // Experimental and Clinical Pharmacology. 2021. V. 84. № 2. P. 84.
  9. Seredenin S.B., Voronina T.A., Neznamov G.G., Zherdev V.P. [Phenazepam: 25 years in medical practice]. M.: Nauka, 2007. 380 p.
  10. Oliynyk S., Oh S.-K. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance // Biomol. Ther. 2012. V. 20. № 5. P. 446.
  11. Ermer J., Homolka R., Martine P. et al. Lisdextramfetamine dimesylate: Linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacockinetic study in healthy adult volunteers // J. Clin. Pharmacol. 2010. V. 50. № 9. P. 1001.
  12. Aleksandrovsky D.D., Maksimov M.L. [Mesocarb efficiency in relieving asthenic conditions in patients taking antipsychotic drugs, as well as prospects of its use in pathologies of the brain dopaminergic system] // Chief Medical Officer. 2022. № 6. P. 54.
  13. Kovalzon V.M. [Fundamentals of somnology: Physiology and neurochemistry of the wakefulness–sleep cycle] (electronic resource). 2nd ed. Moscow: BINOM. Knowledge Laboratory, 2013. 239 p.
  14. Kovalzon V.M. Orexin/hypocretin system of the brain in the regulation of wakefulness and sleep // Effective Pharmacotherapy. 2016. V. 19. (Neurology and psychiatry. Special issue “Sleep and sleep disorders – 4”). P. 6.
  15. Novikov V.S., Soroko S.I., Shustov E.B. [Maladaptation states of a person under extreme influences and their correction]. St. Petersburg: Politekhnika-print, 2018. 548 p.
  16. Novikov V.S., Fateev I.V., Shustov Ye.B. [Prospects and physiological grounds of choosing ways of influencing human performance under extreme conditions] // Herald of education and science development of Russian Academy of Natural Sciences. 2020. № 1. P. 89.
  17. Zvartau E.E., Kalinin V.N. [Bupranal: a new highly efficacious Russian analgesic] // Voen. Med. Zh. 2000. V. 321. № 8. P. 46.
  18. Kubinin A.N., Pchelintsev M.V. [Opioid analgesics: ways to improve the therapy of pain syndromes] // Russ. Med. J. 2007. V. 15. № 5. P. 417.
  19. Alekseeva I.V., Abramova A.Yu., Pertsov S.S. [Nociceptive sensitivity under stress influence] // Russ. J. Pain. 2022. V. 20. № 3. P. 42.
  20. Gordeev S.A. [Pain: Classification, the structurally functional organization of the nociceptive and antinociceptive systems, electroneuromyographic research methods] // Usp. Fiziol. Nauk. 2019. V. 50. № 4. P. 87.
  21. Chepur S.V., Pluzhnikov N.N., Saiganov S.A. et al. Dynamics of virulence of commensals: Preventive phenotipical mutability // Biology Bulletin Rew. 2023. V. 13. № 6. P. 537.
  22. Lyte M. The role of microbial endocrinology in infectious disease // J. Endocrinol. 1993. V. 137. № 3. P. 343.
  23. Freestone P.P.E. Communication between bacteria and their hosts // Scientifica. 2013. V. 2013. P. 361073.
  24. Murakami T., Kamada K., Mizushima K. et al. Changes in intestinal motility and gut microbiota composition in a rat stress model // Digestion. 2017. V. 95. № 1. P. 55.
  25. Sobczak M., Salaga M., Storr M.A., Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: Current concepts and future perspectives // J. Gastroenterol. 2014. V. 49. № 1. P. 24.
  26. Alexander W. Pharmacotherapy for post-traumatic stress disorder in combat veterans: Focus on antidepressants and atypical antipsychotic agents // Pharm. Ther. 2012. V. 37. № 1. P. 32.
  27. Martenyi F., Soldatenkova V. Fluoxetine in the treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial // Eur. Neuropsycopharmacol. 2006. V. 16. № 5. P. 340.
  28. Watts B.P., Schnurr P.P., Mayo L. et al. Meta-analysis of the efficacy of the treatments for posttraumatic stress disorder // J. Clin. Psychiatry. 2013. V. 74. № 6. P. e541.
  29. Bajor L., Ticlea A.N., Osser D.N. The Psychopharmacology Algorithm project at the Harvard South Shore program: An update on posttraumatic stress disorder // Harv. Rev. Psychiatry. 2011. V. 19. № 5. P. 240.
  30. Strygin K.N. [The role of central histamine receptor blockers in the treatment of insomnia] // Zh. Nevrol. Psikhiatr. Im. S.S. Korsakova. 2018. V. 118. № 4–2. P. 73.
  31. Kovalzon V.M. The role of histaminergic system of the brain in the regulation of sleep-wakefulness cycle // Fiziologiia Cheloveka. 2013. V. 39. № 6. P. 13.
  32. Gladkikh V.D., Elkin A.I., Ivanov V.B., Nazarov V.B. [Toxicology of blockers of GABA-dependent chlorine ion channels of neuronal membranes: experimental and theoretical aspects]. Moscow: MA RChBF, 2007. 248 p.
  33. Seredenin S.B., Rybina I.V., Khlopushina T.G., Zherdev V.P. [The determination of the oxidation phenotype in inbred C57Bl/6 and BALB/c mice] // Biull. Eksp. Biol. Med. 1990. V. 110. № 11. P. 491.
  34. Bashkatova V.G., Sudakov S.K. [Modern approaches to the study of genetically determined resistance of laboratory animals to stress loads (review)] // Bull. Med. Sci. 2018. V. 1. № 9. P. 34.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russian Academy of Sciences, 2024